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1. Introduction 
Magnetic resonance imaging (MRI) has been recognized as a powerful 
and intrinsically non-invasive methodology for diagnosis. At the same time 
MRI is not associated to radioactivity problems and hence it is considered 
safe. Getting profit from high resolution, anatomical MR Imaging provides 3D 
tomography none invasively in living systems.  
MRI is based on Nuclear Magnetic Resonance (NMR). On the one hand, 
medical field employs magnetic resonance imaging (MRI), a multidimensional 
NMR imaging technique, for diagnostic purposes. For many diseases, 1H 
MRI has become the main modality of choice for the medical experts 
because it images water from inside the body. On the other hand, chemists 
have also largely exploited the NMR technique. They also contribute to 
magnetic resonance imaging field by designing contrast agents and reporter 
molecules based on relaxation of hydrogen atoms presents in water media.  
Relaxation times of H atoms under magnetic field differ due to their 
surrounding atmosphere or because a restrictive mobility of water molecules. 
The difference between relaxation times is displayed as different signal 
intensity per voxel in MRI giving rise to an image with regions of different 
contrast. 
Indeed, 1H MRI has been extensively used due to the fact that adult 
human body contains about 50 to 65 per cent of water in average. Certainly, 
it is an interesting modality due to its good special resolution and also 
because of its reasonable sensibility towards contrast agent detection. 
Nonetheless, the intense proton background causes sometimes insufficient 
discrimination of damaged tissues from healthy ones.1 This lack creates the 
necessity to explore new approaches such as the use of contrast agents or 
the use of heteronucleus MRI to enhance the contrast.  
Probe’s imaging relaxation time is a meaningful parameter to take into 
account to understand 1H MRI probes classification in MRI.  Probes altering 
                                                          
1Oishi, M.; Sumitani, S.; Nagasaki, Y. BioconjugateChem. 2007, 18, 1379-1382.  
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T1 and T2 relaxation times of surrounding water in the body offer brighter and 
darker images, respectively.  
An important advancement in the heteronucleus MRI as complementary 
technique to proton based MRI, is the fluorine 19 based MRI (19F MRI). 19F 
MRI may be capable of producing high-contrast in vivo images, since there is 
no endogenous 19F in the body that might be a source of background noise.2 
Integrating these two imaging modalities (1H and 19F MRI), one can take 
advantages of both to identify and diagnose pathologies more accurately and 
robustly. In addition, common drugs include a fluorine atom, therefore 
fluorine is largely present in drug based treatments of numerous diseases, 
thus they are obvious candidates to apply this 19F MRI technique.3 In other 
cases, a fluorine atom may be added as a simple tracking molecule to 
interrogate some parameter, such as pO24, pH5 or gene activity.6 
19F has a nuclear spin of ½ and a gyromagnetic ratio (γ) of 40.05 MHz/T.7 
Note that 19F is the only stable isotope of fluorine, it is 100 % naturally 
abundant and has magnetic resonance sensitivity nearly as high as that of 
proton. The NMR sensitivity of 19F is 0.83 relative to 1H.8 
The high gyromagnetic ratio (γ) is only about 6 % lower than that of 
proton, and it generally allows the use of existing proton NMR 
instrumentation with minimum of component adjustments.  
The 19F signal provides an opportunity to image body organs which lack 
water where contrast 1H MRI is handicapped by missing signal (e.g. lungs).9 
                                                          
2Tirotta, I.; Dichiarante, V.; Pigliacelli, C.; Cavallo, G.; Terraneo, G.; Bombelli, F. B.; Metrangolo, P.; 
Resnati, G. Chem. Rev. 2015, 115, 1106-1129. 
3 Kirk, K.L. J. Fluorine Chem .2006, 127, 1013-1029.  
4 Thomas, S.R.; Millard, R.W.; Pratt, R.G.; Shiferaw, Y.; Samaratunga, R.C. Art. Cells, Blood Subs., and 
Immob. Biotech. 1994, 22, 1029-1042. 
5Preslar, A.T.; Tantakitti, F.; Park, K.; Zhang, S.; Stupp, S.I.; Meade, T.J. ACS Nano. 2016, 10, 7376-7384. 
6Gambhir, S.S.; Barrio, J.R.; Herschman, H.R.; Phelps, M.E. Nucl. Med. Biol. 1999, 26, 481-490. 
7 Yu, J.; Kodibagkar, V.D.; Cui, W.; Mason, R.P. Curr. Med. Chem. 2005, 12, 819-848.   
8 Ruiz-Cabello, J.; Barnett, B.P.; Bottomley, P.A.; Bulte, J.W.M. NMR Biomed. 2011, 24, 114-129. 
9Flögel, U.; Ding, Z.; Hardung, H.;Jander, S.; Reichmann, G.; Jacoby, C.; Schubert, R.; Schrader, J. 
Circulation. 2008, 118, 140-148. / Fox, M.S.; Gaudet, J.M.; Foster, P.J. Magn. Reson. Insights.2015, 8, 53-
67. 
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Because nanoparticles provide with new properties and behave differently 
than small molecules it is possible to design new applications such as their 
use as contrast agents. 
Since there is no endogenous 19F signal, there is always the need to 
introduce an external fluorine labelled probe in order to obtain an image. 
Because there is no interference from image background, all which is 
displayed on 19F MRI is directly proportional to the probe concentration, 
allowing an absolute quantification (non relative).  
Frequently employed 19F probes are based on perfluorocarbons (PFCs). 
These are hydrocarbons wherein al C-H bonds have been replaced by C-F 
bonds, which have solubility and stability issues and often multiple signals in 
19F NMR which lead to artifacts in MRI. 
Hence, nanomaterials are an excellent alternative for currently in use 
fluorine based MRI probes. Some of the earliest biomedical applicationsof 
19F NMR used fluorine labelled substrates to explore enzymatic activity and 
protein structures. To obtain detectable signals, spectra, or images, sufficient 
fluorinated probe must be administered, though the probe’s concentration in 
studies of living organisms should be as low as possible to avoid 
physiological perturbations or toxic side effects (Figure 1.1). 
 
 
 
Figure 1.1: 19F NMR PFCs examples of isoflurane and perfluoro-15-crown-5-ether 
displaying the importance of the F load on peak intensity.  
However, in order to achieve a good quality of image comparable to those 
obtained with 1H MRI (or at least acceptable), a high load of fluorine atoms is 
required. Hence, the main challenge in this field is to introduce high fluorine 
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amount in a probe, but conquer fluorine insolubility in water for medical 
applications, which is not easy due to the intrinsic hydrophobicity conferred 
by fluorine atoms.  
Recently, our research group10 has designed a novel nanostructure that 
overcomes the intrinsic hydrophobic nature of fluorinated compounds by 
using a long PEG chain. Ensuring ligand mobility due to PEG structure also 
ensures a successfully colloidal stable system in water and a good signal in 
19F MRI. 
  Additionally these nanoparticles display a sharp single 19F NMR signal 
which could also be imaged by 19F MRI.10 The lack of background signal 
allows for the absolute quantification of the signal that is directly proportional 
to the probe concentration. Synthesis of nanoparticles tagged with fluorinated 
ligands resonating all of them at the same frequency is achieved only through 
chemical equivalent fluorine atoms on the ligands. In this case employing 
symmetrical fluorinated probe they have sorted out signal’s splitting issue 
(Figure 1.2).  
 
 
 
Figure 1.2: Nanostructure designed by our research group. 
Due to the lack of background signal existing in 19F MRI, fluorinated 
probes have become excellent candidates for OFF/ON probe systems, which 
consist of probes that are silent in MRI until a selected trigger activates the 
signal. These types of probes are interesting because they provide additional 
functional information on biological processes in real time.11 
Further, fluorine in vivo is present mostly in the form of solid fluorides, in 
bones and teeth, for this reason endogenous fluorine has a very short T2 
                                                          
10Michelena, O.; Padro, D.; Carrillo-Carrion, C. del Pino. P.; Blanco, J.; Arnaiz, B.; Parak, W.J.; Carril, M. 
Chem. Commun. 2017, 53, 2447-2450. 
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relaxation time on MRI and the resulting signal is below the limits of MRI 
detection in most biological systems of interest.11 
As mentioned before, OFF/ON, activable or smart probes are systems, 
where signal is OFF temporarily and then it is activated to an ON state by an 
external incentive. All activatable probes share the same feature: an external 
stimulus is needed.   
A variety of stimuli-sensitive 19F probes have been developed so far. 
Probes reported on the literature can be classified based on their trigger, 
mainly by pH, redox atmospheres or enzyme responsive. Upon stimulation, 
these designed molecules turn into an ON state in a specific environment.  
For instance, there are pH responsive MRI probes which are suitable for 
tumor cells detection due to the fact that pH values within tumor cells range 
from 5.5 to 6.8, being these values lower than those in healthy cells. In many 
cases detection of pH by 19F MRI pH responsive probes is based on the 
mobility of the fluorinated probe within a polymeric matrix. 
Selectively designed matrixes get protonated under specific pH 
environment, then the hydration leads to gel swelling allowing fluorine 
mobility and hence activating the MRI signal. 
Chen12 et al. have designed a nanosized pH triggered probe based on the 
encapsulation of a fluorinated probe into mesoporous silica nanoparticles 
(MSN) cavities that were capped with gold nanoparticles. Those gold 
nanoparticles were bond onto silica’s surface by hydrazone linkage, which is 
pH sensitive. At neutral pH 7.4 the hydrazone linkers remain intact, thus, 
pores are blocked with AuNPs. At pH lower than 6 hydrazone’s bond goes 
through a hydrolysis reaction releasing gold nanoparticles onto the surface, 
thus, opening the gate to release C6F6 contrast agent turning ON the smart 
probe (Figure 1.3). 
                                                          
11Carril, M. J. Mater. Chem. B.2017, 5, 4332-4347. 
12 Chen, S.; Yang, Y.; Li, H.; Zhou, X.; Liu, M. Chem. Commun.2014, 50,  283-285.  
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Figure 1.3: Chen’s pH trigger bioprobe design (Cylinders are MSNs, Yellow spheres are 
gold nanoparticles blocking surface cavities. Pink hexagons are C6F6 fluorine contrast agent) 
Another type of OFF/ON probes are redox responsive MRI probes, which 
are suitable for tumor cell detection because of their reducing environment 
due to the presence of glutathione. 19F MRI probes play with paramagnetic 
metals in the neighborhood of 19F nuclei by PRE (paramagnetic relaxation 
enhancement). If the metal is nearby 19F nuclei this is deactivated on MRI, 
besides, when the metal is faraway from19F nuclei, then19F signal becomes 
active on MRI.  This effect allows reversible switch OFF/ON of fluorine probe. 
Hypoxia is an oxygen deficiency condition experienced in solid tumor 
cancers and also in other pathologies. Que13 et al. have developed a copper 
based probe where Cu(II)/Cu(I) pairs are used to switch OFF and ON the 
fluorine signal based on Paramagnetic Relaxation Enhancement (PRE) 
effect.  
In this case, the molecule reported is a chelate with a fluorinated side 
chain. When fluorine atoms are close to Cu(II) are inactive on 19F MRI. 
However, once Cu (II) is reduced to Cu (I) by hypoxic cells 19F MRI signal is 
turned ON (Figure 1.4).  
 
 
Figure 1.4: Schematic representation of Que’s bioresponisve probe regulated by PRE 
effect.  
                                                          
13Xie, D.; King, T.L.; Banerjee, A.; Kohli, V.; Que, E.L. J. Am. Chem. Soc.,2016, 138, 2937-2940.  
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Enzyme responsive MRI probes are one of the main areas of interest, 
being enzymes an indicator of pathologies progression due to its 
deregulation and also a disease symptom indicator.  
Yuan14 et al. have designed a fluorine probe for imaging caspase 3/7 
enzymatic activity in vivo which is a cellular apoptosis indicator studied in 
tumor therapy. The probe design is based on trapping fluorinated compounds 
in nanoparticles formed by glutathione induced self assembly of DVED 
peptide, which is a substrate for caspase 3/7, as the 19F MRI OFF state. 
Then, in the presence of caspase 3/7, DVED peptide gets digested and 
disassembles the macrostructure releasing the fluorinated probe and hence 
activating the ON state. The in vivo test has been carried out on zebrafish 
model (Figure 1.5).  
 
 
Figure 1.5: Yuan’s smart probe design.  
 
In the present work, we have designed and synthesized a novel probe 
with potential application as enzyme responsive smart probe for 19F 
MRI. On this new approach, the target enzyme is metalloproteinase 9 (MMP-
9) which has been strategically chosen as the trigger due to its role in several 
disease pathways.    
Matrix metalloproteinases (MMPs) are involved in many physiological and 
pathological processes,15 due to their ability to cleave and remodel 
components of surrounding tissues. MMPs may affect cell migration, 
differentiation, neovascularisation, wound healing, apoptosis, growth, 
                                                          
14 Yuan, Y.; Sun, H.; Ge, S.; Wang, M.; Zhao, H.; Wang, L.; An, L.; Zhang, J.; Zhang, H.; Hu, B.; Wang, J.; 
Liang, G. ACS Nano, 2015, 9, 761-768.  
15 Murphy, G.; Nagase, H.; FEBS J,2010, 278, 2-15.   
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inflammatory process, urine cycleand many other actions within the body as 
tumorigenesis and other diseases.16 
More than 20 classes of MMPs have been identified in humans, labelled 
from MMP-1 to MMP-28. MMPs are located onto cell surface where 
selectively degrade various components of extracellular matrix (ECM). 
Hence, MMPs play crucial roles in invasion and metastasis and regulate 
signalling pathways that control cell growth, survival, invasion, inflammation 
and angiogenesis.    
High levels of MMP-2 and/or MMP-9 are found in breast, brain, ovarian, 
pancreas, colorectal, bladder, prostate and lung cancer and melanoma. 
Dysregulated MMP expressions is also observed in haematological 
malignancies.12 MMPs also are present in cardiovascular field as in stroke, 
aneurism and atherosclerosis. Specifically MMP-2 (gelatinase A) and MMP-9 
(gelatinase B) differ from most of the other MMPs in that they have a 
collagen-binding domain (CBD) within the catalytic domain (Figure 1.6). 
Furthermore, gelatinases generate or release bioactive molecules that 
influence tumour’s  progression.12 
 
 
Figure 1.6: First, the general domain structure of MMP family; Pre: guides the MMP into 
the rough endoplasmic reticulum during synthesis; Pro: sustains the latency of MMP. The 
catalytic domain houses a highly conserved Zn2+ binding region; PEX: hemopexin-like-C-
terminal Secondly the gelatinases contain the collagen  binding domain (CBD)  by Bauvois.17 
 
There are several possible reasons for the failure of MMP’s detection in 
the clinic. Firstly, most of the MMPs have dose-limiting musculoskeletal 
toxicity that limits efficacy. Secondly, the clinical trials were performed on 
patients with terminal-phase cancer, where several overlapping pathways 
                                                          
16Krizkova, S.; Zitka, O.; Masarik, M.; Adam, V.; Stiborova, M.;Eckschlager, T.; Chavis, G.J.; Kizek, R. 
Trends Anal. Chem.2011, 30, 11.  
17Bauvois, B. BiochimBiophysActa.2012, 1825, 29-36.  
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come into play. Thirdly, the structural similarities of the various MMP’s 
catalytic domains make it difficult to design probes for MMPs with high 
selectivity.18 
Being gelatin the substrate for our MMP-9 and being also extensively 
reported on literature as a drug delivery vehicle, we believe gelatin 
nanoparticles can be an excellent system to be used as a carrier for 
fluorinated probes and at the same time act as a substrate for our trigger 
(MMP-9) constructing in this manner a MMP-9 responsive OFF/ON probe for 
19F MRI.  
It isessential to understand the purpose of encapsulation and the 
mechanism for nanoparticles release for the rational design of encapsulated 
particles, from selection of the appropriate matrix material and formulation of 
capsule to obtain structures that protect the core and respond appropriately 
to the desired stimulus. 
In the development process of a nanoparticle delivery system for in vivo 
application, biodegradability without toxic by products is one of the major 
claims. Collagen and gelatin have raised specific interest as promising 
delivery vehicle for controlled release of biomolecules such proteins, 
nucleotides and metal core nanoparticles as we are going to discuss further 
in the present work. 
Due to collagen intrinsic protein structure with high number of different 
accessible functional groups, gelatin endows multiple modification 
opportunities for coupling of targeting ligands, crosslinkers, and shielding 
substances.  
Utilizing MMPs as target for in-vivo imaging is a relatively young approach. 
Notwithstanding the extensive literature on this subject, there are no good 
imaging probes reported for MMP gelatinases detection.  
Getting information about dynamic processes and functional information in 
real time through smart and bio-responsive probes is crucial to make a more 
specific diagnosis. We have explained several examples of OFF/ON contrast 
                                                          
18Overall, C.M.; Kleifeld, O.; Br. J. Cancer, 2006, 94,  941-946.  
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agents. Ideally MRI detection would require an initial non-detectable probe 
(OFF state) to a detectable probe system (ON state) by contrast agent.  
 
Spotlighting the present work in key points; firstly enzyme responsive 
probes on MRI imaging are potential biomarkers through trigger. Secondly, 
nanoparticles play an important role as delivery system. Lastly, 
metalloproteases are a potential trigger on gelatine substrates. So, a novel 
19F MRI smart probe has been designed for potential OFF/ON detection 
of MMP-9. 
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2. Objectives 
The present work deals with the synthesis of fluorine labeled gold 
nanoparticles followed by their encapsulation in gelatin nanoparticles. The 
choice of gelatin is based on its role as substrate for gelatinases MMP 
enzymes (MMP-2/9). Hence, our hypothesis is that when our fluorine labeled 
NPs are encapsulated in gelatin the 19F MRI signal would be OFF. The 
disassembly of the gelatin NPs triggered by its digestion by MMPs should 
lead to the turning ON of the signal (Figure 2.1). The specific goals are listed 
below: 
 
1. Optimization of the synthesis and characterization of gelatin 
nanoparticles of 250-350 nm diameter.  
 
2. Synthesis and characterization of fluorine-labeled gold 
nanoparticles, following already established procedures in our 
laboratory. 
 
3. Design and optimization of an efficient encapsulation pathway for 
loading gelatin NPs with F-labeled Au NPs and characterization of 
the so-obtained materials. 
 
4. Demonstrate via 19F NMR that the signal of fluorine labeled gold 
nanoparticles is quenched by gelatin encapsulation (OFF state) as 
a validation of our design of a bioresponsibe probe.  
 
 
17 
 
 
 
Figure 2.1: Schematic representation of our probe design and the main aim of the present work. 
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3. Results and Discussion 
3.1. Gelatin nanoparticles’ synthesis 
In the present work, gelatin nanoparticles have been chosen as a 
promising vehicle due to theirbiocompatibility; ease of manipulation and also 
due to their potential to target matrix metalloproteinase 9 enzyme (MMP-9). 
Collagen as an extracellular protein matrix is present in bones and 
tendons (90%) and skin where 50% of this matrix is collagen, which is the main 
way to obtain gelatin by denaturalization treatment of animal collagen (Figure 
3.1). The amino acid composition of collagen and hence of gelatin is about 33% 
glycine, thus, Gly-X-Y represents the continually repeating amino acid 
sequence. 
 
 
 
Figure 3.1: Structural transformation of collagen into gelatin.(http://imgur.com/TdOJOwh) 
 
At the present work gelatin type A from porcine skin has been employed to 
conduct the synthesis and characterization of gelatin nanoparticles, which are 
intended to act as a trigger on the activatable bioprobe targeting MMP-9, also 
known as gelatinase enzyme.  
Since molecular gelatin composition is heterogeneous, the preparation of 
homogeneous nanoparticles in size is challenging. Desolvation of the 
19 
 
commercial gelatin protein was chosen as the pathway to synthesize nanosized 
gelatin particles. 
Gelatin is soluble in water in all its widespread of molecular weights as 
obtained from natural commercial sources. To achieve gelatin nanoparticles 
homogeneity in size, a narrow molecular weight (Mw) range is desired.  
According to literature, two step desolvation method consisting of adding a non 
solvent and then adjusting the pH to the pI of gelatin enables the preparation of 
homogeneous gelatin spheres.19 
Based on our experience, the key to succeed in our gelatin nanoparticle 
synthesis is to work at a pH value higher than the first pKa of gelatin. In this 
situation, carboxyl groups will be mainly present as carboxylatesand will favor 
precipitation of gelatin nanoparticles in the desolvating solvent, usually acetone. 
Determination of optimum pH was one of the most challenging points. In our 
case, pH = 3 was selected as the best working conditions after several trials at 
different pH values between 2.5 and 4. This range was selected based on the 
fact that the majority of collagen aminoacids reach their first pKa between 2.5 
and 4. 
Once gelatin dissolved in water gets in contact with acetone or ethanol, 
the biggest molecular weight chains immediately precipitate. Acetone has been 
chosen as the desolvation solvent in our case due to the numerous reports that 
use acetone.20 The water/acetone ratio in the first desolvation step is 1/1 (v/v) 
and the time the gelatin is allowed to precipitate after acetone addition (1 min in 
our case) will determine the amount and also the Mw range of the gelatin 
precipitate obtained. Hence, these are key factors to be controlled for synthetic 
reproducibility. 
Then, once a narrow range of Mw has been obtained after the first 
desolvation step, a second desolvation step is required to form NPs by 
controlled dropwise addition of acetone, after which NPs are immediately 
formed as evidenced by the turbidity observed. Gelatin insolubility in acetone is 
the reason why protein chains fold on themselves. In this manner nanospheres 
                                                          
19Coester, C.J.; Langer, K.; Briesen, H.V.; Kreuter, J. J. Microencapsulation, 2000, 17, 187-193.  
20Gaihre, B.; Khil, M. S.; Lee, D. R.; Kim, H. Y. Int. J. Pharm. 2009, 365, 180-189. 
20 
 
are spontaneously shaped. This kind of interaction is weak, thus the so-
obtained nanoparticles will not remain stable over time unless crosslinked 
(Figure 3.2).  
 
 
 
Figure 3.2: Gelatin polymer chain at pH = 3 on left. Gelatin chains already crosslinked by 
amidation bond on right side. 
 
The most common crosslinker in gelatin nanoparticles formation is 
glutaraldehyde (GA)21 but we chose EDC/NHS for biocompatibility, since GA is 
known to be toxic.22 
Chemical crosslinking agents can be classified into non zero-length and 
zero length crosslinkers. Non zero-length agents introduce poly- and 
bifunctional crosslinkers into the network structure by bridging free amine 
groups (from lysine and hydroxylysine) or by free carboxylic acid residues (from 
glutamic and aspartic acid) of the protein molecules. Glutaraldehyde is widely 
used in literature. The disadvantage of these agents is that the crosslinkers are 
built into the biomaterial. These reactive and/or even toxic compounds may 
leach into the body upon biodegradation of the hydrogel.23 
Zero-length crosslinkers do not imply incorporation of a foreign structure 
into the network. The most common pathway is by activating carboxylic acid 
residues to react with free amine residues, which resultsin the formation of an 
amide bond, ensuring that external compounds do not remain in the 
nanoparticles. Acyl azide method and the carbodiimide crosslinkings are 
                                                          
21 Reis, C.P.; Neufeld, R.J.; Ribeiro, A.J.; Veiga, F. NANOMED-NANOTECHNOL, 2006, 2, 8-21. 
22Fürst, W.; Banerjee, A. Ann. Thorac. Surg., 2005, 79, 1522-1528. 
23Kuijpers, A.J.; Engbers, G.H.; Krijgsveld, J.; Zaat, S.A.J.; Dankert, J.; Feijen, J. Biomater. Sci. Polym. Ed., 
2000, 11, 3. 
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representative of this class of crosslinkers for gelatin or collagen substrates. 
Since toxic hydrazine is employed in the acyl azide linkage method,24 
carbodiimide pathway has been considered a safe bet in the present work 
(Scheme 3.1). 
Since most of the methods reported in literature use GA, we needed to do 
an extensive optimization to achieve more or less monodisperse gelatin 
nanoparticles using EDC/NHS as crosslinking agents.25 
The two crucial factors to control the results are the protein amount after 
the first desolvation step and the pH value before the second desolvation step. 
But also the amounts of crosslinker and addition rates are of high importance 
when we talk about size homogeneity, especially if later release of entrapped 
cargo and degradation kinetics are concerned.  
 
 
Scheme 3.1: EDC/NHS crosslinking reaction on gelatin.26 
                                                          
24PandurangaRao, K.; J. Biomater. Sci. Polym Ed, 1995, 7, 623-645.  
25Qazvini, N.T.; Zinatloo, S.; J. Mater. Sci., 2011, 22, 63-69. 
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Reported by Kuijpers et al., crosslinking of proteins with carbodiimide is 
generally considered to take place according to the mechanism on Scheme 3.1. 
Carbodiimide (II) activates carboxylic acid residues of aspartic and glutamic 
acid (I) resulting in the formation of O-acylisourea groups (III). Crosslinked 
compound (V) can be formed by nucleophilic attack of free amine groups of 
lysine and hydroxylysine residues (IV) on the activated carboxylic acid residues, 
with urea derivative as a leaving group. Possible secondary reactions of such 
linkage are hydrolysis of the O-acylisourea group, resulting in the formation of a 
carboxylic acid group (I), and rearrangement of the O-acylisourea group into a 
stable N-acylurea group (VI). The use of N-hydroxysuccinimide (NHS) (VII) in 
the crosslinking reaction gives an NHS activated carboxylic acid group (VIII), 
which is less susceptible to hydrolysis, and prevents rearrangement. All 
residues are water soluble, and can be effectively washed out of the gel after 
crosslinking.  
There are a number of reports on the literature to prepare gelatin NPs 
mainly using GA as crosslinker and leading to nanoparticles of varied sizes 
depending on the reaction parameters employed. In our case, for encapsulation 
purposes we aimed at NPs of approximately 250 nm in diameter so that we 
could allocate a good number of gold nanoparticles inside but they are not 
excessively big for bioapplications. For this reason, we first needed to optimize 
all reaction parameters only with gelatin before testing encapsulation. 
In addition, it has to be mentioned that robustness in reproducibility is 
challenging and can only be achieved by extremely methodic working 
conditions and accuracy. 
Preliminary optimization from the group based on the protocol reported by 
Wong et al.27 set the pavement for the initial conditions tested and after 
variation of few parameters we managed to obtain homogeneous gelatin NPs in 
size and in a reproducible manner. 
                                                                                                                                                                          
26Kuijpers, A.J.; Engbers, G. H.M.; Krijgsveld, J.; Zaat, S. A. J.; Dankert, J.; Feijen, J. J. Biomater. Sci. 
PolymerEd, 2000, 3, 225-243.  
27 Wong, C. Stylianopoulos, T. Cui, J.; Martin, J.; Chauhan, V.P.; Jiang, W.; Popovic, Z.; Jain, R.K.; Bawendi, 
M.G.; Fukumura, D. PNAS, 2010, 108, 2426-2431. 
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The optimized parameters for the synthesis of gelatin nanoparticles are 
the following: 
- Temperature reaction: 50ºC 
- Stirring: 750 rpm 
- pH= 3.00 
- Acetone addition rate (2n desolvation step): 1 mL/min 
- EDC/NHS ratio: 3.5:1, added in a 0.9 % aqueous solution. 
- EDC/NHS solution addition rate: 0.1 mL/min 
- 1 hour reaction time after EDC/NHS addition. 
 
Work temperature has been established at 50 ºC due to sol-gel transition 
temperature of gelatin is at 35-40ºC. The fully optimized protocol for the 
synthesis of gelatin nanoparticles is described in detail in the materials and 
methods section and summarized in Scheme 3.2. 
 
 
Scheme 3.2: Schematic representation of the workflow used to prepare gelatin nanospheres. 
 
Considering the applicability of nanoparticles as a vehicle delivery system, 
size is a parameter to take into account. Quality control of the resulting 
nanoparticles is done by DLS (Dynamic Light Scattering) measurements. Size 
distribution of gelatin nanoparticles is determined by their PdI (polidispersity 
index), which in our case ranged between 0.3-0.1.  PdI below 0.1 means that a 
highly monodisperse size distribution have been obtained. As an example of 
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DLS measurement of our gelatin nanoparticles, a size distribution plot by DLS is 
displayed on Figure 3.3.   
 
 
Figure 3.3: DLS distribution showing size by number of three measurements. 
 
The Zetasizer software calculated 277.7 ± 6.30 nm by number as the 
mean size of these particles with a PdI of 0.09 ±0.06 (out of 3 measurements). 
In addition, gelatin nanoparticles have been analyzed by TEM 
(Transmission Electron Microscopy) in order to visualize the particles and 
investigate their morphology. Uranyl acetate based negative stained samples 
analyzed by TEM revealed the sample as smooth spheres of 188.7 ± 36.1 nm 
size, as plotted in Figure 3.4. (Statistics displayed on Figure 3.5). 
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Figure 3.4: Gelatin nanospheres morphology shown by TEM micrographs. 
 
 
 
Figure 3.5: Histogram fitted to a Gaussian distribution of gelatin nanoparticles’ size using Origin 
8.5 software. 
 
We were aware that a significant discrepancy could happen and should be 
seen between DLS distribution and TEM results according to the measurement 
principle of both analytical methods. This is because nanoparticles cannot be 
measured under equal conditions. Indeed, particles under DLS conditions have 
to be dispersed in a solvent, whereas TEM preparation sample requires drying 
the particles under vacuum conditions.  
Hence, while DLS measures hydrodynamic diameter (dh) of gelatin 
nanoparticles in solution, particles measured under the TEM suffer a shrinking 
in their diameter size by sample’s dehydration.   
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Once gelatin parameters have been optimizedwe moved on to our next 
goal, that is, encapsulation of fluorinated gold nanoparticles to obtain a 
potentially activatable probe to image MMP-9 activity by 19F MRI.  
 
3.2. Synthesis of fluorine labeled gold nanoparticles. 
Following with the research line of our group in which gold NPs are 
labeled with fluorinated ligands for potential 19F MRI applications, five NPs with 
different degree of fluorination or methoxy groups were synthesized following 
the reported procedure.10 
Such fluorinated gold NPs previously described by us are composed of an 
inorganic gold core and an organic shell. Such organic shell is based on 
polyethylene glycol (PEG) ligands due to their water solubility. Those PEG 
ligands have a thiol moiety for gold NP synthesis and are either modified with a 
methoxy group or a perfluorinated tert-butanol derivative. The methoxy modified 
NPs were selected as model NPs for preliminary optimization of the 
encapsulation process, although the main goal is the encapsulation of the 
fluorinated NPs. We already proved that the latter NPs are active in 19F MRI 
(Figure 3.6).10 
 
 
Figure 3.6: Fluorine labeled gold nanoparticles reported recently by our group.10 
 
Methoxy functionalized PEG was commercially available but fluorinated 
PEG ligand was synthesizedin the laboratory as described by us and shown in 
Scheme 3.3. 
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Scheme 3.3: Synthesis of fluorinated PEG ligand. 
 
In addition, in order to test different encapsulation strategies, as it will be 
described below, NPs combining either fluorinated or methoxy PEG with 
commercially available carboxylated PEG derivative were synthesized. NPs 
were prepared following the established procedure by us consisting of 
chloroauric acid reduction by NaBH4 in the presence of enough thiolated ligands 
to stabilized the so-obtained gold NPs. 
As mentioned before, initially, surrogate NPs with a methoxy group instead 
of fluorine were prepared to pre-optimize encapsulation reaction. The amount of 
ligand used to stabilize each NP was set to 0.45 equivalents in total with respect 
to chloroauric acid, as it was already optimized in the laboratory. For mixtures of 
ligands, the 0.45 equivalent total value was maintained and the percentages 
shown in Table 3.1 are considering that 0.45 is the 100%. Synthetic procedure 
for our gold NP preparation is displayedin Scheme 3.4. 
 
 
Scheme3.4: Schematic representation of the workflow used to prepare NP1-5.10 
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Table 3.1: Ligand ratio distribution onto gold nanoparticles surface 
 
AuNPs NP1 NP2 NP3 NP4 NP5 
Ligand 
ratio 
100% HS-PEG-OMe 75%HS-PEG-OMe 
25% HS-PEG-CO2H 
100% HS-PEG-F 75%HS-PEG-F 
25% HS-PEG-CO2H 
90% HS-PEG-F 
25% HS-PEG-CO2H 
 
Transmission electron microscopy of NP cores 
Transmission Electron Microscopy (TEM) analysis allows a direct 
measurement of the size and shape of NPs. The organic ligand shell typically 
does not provide sufficient electron contrast, and thus in TEM images only the 
inorganic part of the NPs can be seen. Also the state of agglomeration can be 
observed. Characterization of the gold core size was carried out only by 
transmission electron microscopy because DLS technique is imprecise for 
particles under 10 nm. We show in Figure 3.7 the TEM micrographs and size 
distributions of NP1-5. As expected for the synthetic methodology employed, 
the size of the so-obtained NPs is about 4 nm in diameter, as shown in Table 
3.2. 
 
NP1 
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NP2 
 
 
NP3 
 
 
NP4 
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NP5 
 
Figure 3.7: On the left side, TEM micrographs of each NP synthesized. On the right side, 
histograms with Gaussian distribution for each NP. 
 
Table 3.2: TEM diameter size (nm) measured by Image J free software 
 
 NP1 NP2 NP3 NP4 NP5 
dc(nm) 4.75 ± 0.66 3.89 ± 1.17 3.63 ± 0.49 3.88 ± 0.63 3.77 ± 0.55 
 
As inorganic cores can be conveniently imaged with transmission electron 
microscopy (TEM), the mass of one NP core can be obtained. In addition to the 
NPs' core material density, the NP core volume Vc could be calculated using 
NP dimensions as obtained from TEM images (core diameter (dc)). Note, that 
without additional staining the organic shell does not provide contrast in regular 
TEM, thus only the inorganic cores are visible. In case of spheres the volume of 
one NP core is: 
 
In case the core is composed out of material of known density, the mass 
of one NP core is: 
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For most inorganic NP materials their densities can be found in the 
literature. The molar mass of an NP core thus is: 
 
To give an example, for a spherical NP2 with core diameter dc = 3.89·10-
7cm, Vc = (𝜋/6) × (3.71·10-7cm)3 = 3.08·10-20cm3. Given the bulk density of Au 
of 𝜌Au = 19.3 g/cm3, the mass of one Au core thus is mc = 19.3 g/cm3 × 3.08·10-
20cm3 = 5.95·10-19 g. The molar mass of an Au core thus is Mc = mc×NA= 
5.17·10-19 g × 6.02·1023 mol-1= 3.58·105g/mol (Table 3.3). With these data and 
together with ICP-MS data analysis it is possible to calculate the concentration 
of gold NPs in a given solution (shown later, Table 3.4). These data are 
important for batch to batch reproducibility in the future encapsulation process. 
 
Table3.3: NPs molecular weight as obtained from TEM diameter measurements. 
 
 NP1 NP2 NP3 NP4 NP5 
Mw (g/mol) 6.54·105 3.58·105 2.91·105 3.55·105 3.26·105 
 
UV/Vis absorption spectroscopy 
UV/Vis absorption spectroscopy is an easy and simple method to 
characterize NPs. Spherical Au NPs of a few nm in size have their surface 
plasmon resonance (SPR) absorption peak around 510 nm28 and do not absorb 
light at higher wavelengths of 800 - 1200 nm. We show in Figure 3.8 the UV-Vis 
spectra of NP1-5 and the SPR wavelength values are summarized in Table 3.4. 
                                                          
28Woehrle, G.H.; Brown, L.O.; Hutchison, J.E. J. AM. CHEM. SOC. 2005, 127, 2172-2183. 
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Figure 3.8: UV-Vis absorption of NP1-5 normalized at λ = 450nm. 
 
Table 3.4: Summary of NPs characterization parameters obtained by TEM, UV-Vis and ICP 
techniques. 
 
 NP1 NP2 NP3 NP4 NP5 
dc(nm) ±σ 4.75 ± 0.66 3.89 ± 1.17 3.63 ± 0.49 3.88 ± 0.63 3.77 ± 0.55 
𝝀 (𝒏𝒎, 𝑺𝑷𝑹) 514 512 510 512 512 
Concentration 
(μM)a 
0.17 0.35 0.42 0.33 0.28 
a Calculated combining ICP-MS data and the Mw summarized in Table 3.3. 
 
The characteristic absorption peaks are responsible for the distinctive 
bright color of NP solutions. The spectral position and shape of the surface 
Plasmon absorption band depends on a variety of factors, such as NP material, 
size, size distribution, shape, surface chemistry, state of aggregation, as well as 
the solvent.29 In our case, considering the gold core size of about 4 nm, SPR 
bands appear where expected in aqueous solution, that is, around 510 nm. 
Due to the high batch to batch reproducibility in the synthesis of these 
types of gold NPs, concentration of the NPs solutions obtained in each 
synthesis was measured by UV-Vis after calibration of absorbance measured at 
λ = 450 nm using ICP-MS data of the first batch of each NP type (NP1-5). 
Hence, for every subsequent batch, absorption of each NP suspension is 
                                                          
29Huehn. J.; Carrillo-Carrion, C.;Soliman, M. G.; Pfeiffer, C.; Valdeperez, D.; Masood, A.; Chakraborty, I.; 
Zhu, L.; Gallego, M.; Yue, Z.; Carril, M.; Feliu, N.; Escudero, A.; Alkilany, A.; Pelaz, B.; del Pino, P.; Parak, 
W. J. J. Chem. Mater 2017, 29, 399-461.  
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recorded, and then the NP concentration in this solution is determined by the 
calibration done with the help of ICP-MS data. (Annex I)  
19F NMR spectra of fluorinated NPs was also recorded to check the 
presence of a single and narrow fluorine signal, corresponding to the presence 
of 9 equivalent fluorine atoms in each ligand on NP3-5 between -70 and -71 
ppm, as shown in Figure 3.9. 
 
 
Figure 3.9: 19F NMR spectra of NP3 (top blue spectrum), NP5 (medium green spectrum) and 
NP4 (bottom red spectrum). 
 
Once gold nanoparticles NP1-5 were prepared and characterized, we 
moved to the next goal, that is, encapsulation of these NPs into gelatin 
nanoparticles, initially only with methoxylated NP1-2 followed by NP3-5 and 
evaluation of the 19F NMR signal only for fluorinated ones. 
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3.3. Encapsulation of gold nanoparticles into gelatin nanosized spherical 
particles. 
Two pathways of encapsulation have been tested, that is, passive 
encapsulation and covalent modification of gelatin chains. 
 
3.3.1 Passive encapsulation by entrapment. (En-Gel). 
Encapsulation by entrapment is obtained by simply adding simultaneously 
together gelatin and gold nanoparticles in solution. After the first desolvation 
step, then, by following exactly the same synthetic procedure as for regular 
gelatin NPs, we obtained gold NPs encapsulated in gelatin NPs by random 
entrapment of gold NPs during the second desolvation step followed by cross-
linking, as described before. 
Initially, we used gold nanoparticles NP1 as surrogates because OMe 
group is non-charged. After initial successful trials with NP1, we attempted 
encapsulation with fluorinated NP3. The general synthetic strategy is depicted 
in Scheme 3.5. 
 
 
Scheme3.5: Schematic representation of the workflow used to prepare En-Gel containing either 
NP1 or NP3. 
 
Optimized parameters for En-Gel procedure: 
- Temperature reaction: 50ºC 
- Stirring: 750 rpm 
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- NPs addition after first desolvation step. 
- pH = 3.00 
- Acetone addition rate (2n desolvation step): 1 mL/min 
- EDC/NHS ratio: 3.5:1 in a 0.9 % aqueous solution 
- EDC/NHS addition rate: 0.1 mL/min 
- 1 hour reaction time after EDC/NHS addition. 
Unfortunately, the amount of NPs encapsulated by passive entrapment 
was very low, and most of the NP1,3 were not incorporated into gelatin (showed 
up further, Table 3.9). Increasing the amount of NPs exposed to gelatin did not 
improve the encapsulation process for which En-Gel method was discarded, 
and a new method has been designedto increase encapsulation efficiency. 
 
3.3.2 Gelatin covalent functionalization with AuNPs. (Au-Gel) 
Molecules with reactive amino or carboxyl groups on gold nanoparticles 
may be coupled to proteins or modified polymeric supports using EDC and NHS 
as activators. Hence, following with this idea, we used our carboxylated NPs 
(NP2, NP4 and NP5) to attach them to the gelatin chains before the 2nd 
desolvation step where gelatin NPs are formed, as it is shown in Scheme 3.6. 
 
 
Scheme 3.6: Activation of gold nanoparticles and binding onto gelatin chains. 
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Being a completely new design not reported before, we did not know how 
many nanoparticles we would be able to attach without compromising the 
crosslinking of the gelatin nanoparticles, and hence an exhaustive optimization 
process was carried out. 
For this strategy, this is how the procedure works: first activation of 
carboxyl groups on gold NPs by EDC/NHS takes place followed by immediate 
reaction with free amino groups on gelatin. Then, this gelatin chains modified 
with gold nanoparticlesis purified by centrifugation. The Au NP modified gelatin 
remains in the pellet and the supernatant are recovered fully transparent, which 
means that all gold nanoparticles have been bound to gelatin. The full 
procedure is shown in Scheme 3.7. 
 
 
 
 
Scheme 3.7: Schematic representation of the workflow used to prepare Au-Gel containing NP3, 
NP4 or NP5. 
 
Next, this new material called Au-Gel (because there are already Au NPs 
attached to gelatin) was used to form gelatin NPs that already incorporate gold 
NPs. Hence, COOH groups from newly modified gelatin chains are 
subsequently activated also by EDC/NHS and reacted with the remaining free 
NH2 groups from gelatin. This second amidation crosslinking step between 
functional groups both from the gelatin follows exactly the same conditions and 
parameters applied on unmodified gelatin chains. 
From previous ICP-MS data collected for similar gold nanoparticles in our 
group,10 it is estimated that there are approximately 140 ligands per 
nanoparticle, out of which 35 are funtionalized with carboxylic groups for NP2 
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and NP4, and 14 for NP5, due to the ligand ratios used in their respective 
syntheses. Therefore, at known concentration of NP2,4-5, we could estimate 
the concentration of carboxylic groups in solution and use this value to calculate 
EDC/NHS equivalents for each gold NP activation conditiontested. Hence, after 
optimization, the parameters for Au-Gel protocol are the following: 
Activation of NPs conditions: 
- Temperature: 40ºC 
- Orbital stirring: 300 rpm  
- Activation time: 30 min  
- EDC/NHS ratio: 1:3 
Covalent binding of activated Au NPs to gelatin chains: 
- Temperature: 50ºC 
- Stirring 750 rpm 
- pH = 3.00 
- NPs addition rate: 0.1mL/min 
- 1 hour reaction time after Au NP addition. 
- Non reacted Au NPs removal by centrifugation 
Gelatin NPs formation with Au NP modified gelatin chains: 
- Acetone addition rate (2n desolvation step): 1 mL/min 
- EDC/NHS ratio: 3.5:1 in a 0.9 % aqueous solution. 
- EDC/NHS addition rate: 0.1 mL/min 
- 1 hour reaction time after EDC/NHS addition. 
Increasing NPs quantities have been tried on this material in order to 
achieve the maximum loading of fluorinated Au NPs inside the gelatin 
nanoparticles as it will be shown in following sections.  
As explained before, preliminary attempts were performed using 
methoxylated NP2 and then we moved first to NP4 and then to NP5. We are 
particularly interested in NP5 because the ratio of fluorinated ligands is higher 
but there are still enough carboxylated ligands (10 %) to link to gelatin. All 
systems tested are summarized in Table 3.5. 
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Table 3.5: Sum up of the nanoparticles used in each encapsulation 
 
 En-Gel1 En-Gel2 Au-Gel1 Au-Gel2 Au-Gel3 
AuNPs contained NP1 NP3 NP2 NP4 NP5 
 
3.3.3. Purification 
Unfortunately the present procedure to encapsulate nanoparticles does 
not synthesize a single size range of nanoparticles, thus, a purification process 
takes place in order to discard undesirable bigger sized nanoparticles. Both 
cases, En-Gel and Au-Gel were purified in the same way. 
After crosslinking reaction at 50 ºC is over, the so-obtained suspension 
was transferred immediately into 50 mL centrifuge tube. The sample was 
centrifuged at 2000 g for 10 min, in order to separate nanoparticles of size 
ranging between 350 and 500 nm by DLS analysis. Pellet was collected and 
supertantant was centrifuged once more at 14000 g for 20 min.  This time, 
obtained pellet is the desirable one, of size between 250-350 nm by DLS 
analysis. Supernanant was discarded (Scheme 3.8). 
Pellets were resuspended in nano-H2O, sometimes with the help of 
temperature or sonication to speed up the process. They can be safely stored at 
4 ºC keeping colloidal properties overtime. Indeed, DLS of selected samples 
was measured after 2 months with no changes in size observed by DLS. 
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Scheme 3.8: Schematic representation of the workflow used to purify En-Gel and Au-Gel 
nanoparticles. 
 
3.3.4 Caracterization of En-Gel and Au-Gel NPs 
Dynamic light Scattering (DLS) 
Dynamic light scattering is a simple and fast technique to measure 
hydrodynamic diameters of NPs and associated PdI. Solvent plays an essential 
role due to hydration/solvation, and also polymer architecture on the NPs in 
each solvent. In addition to measuring dh average, it is possible to determine 
the monodispersity of NP suspensions by measuring polydispersity index (PdI). 
PdI is a unitless parameter that measures the heterogeneity in the NP’s 
hydrodynamic diameter in sample. The DLS results obtained for En-Gel are 
summarized in Table 3.6, and those of Au-Gel are in Table 3.7. 
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Table 3.6:En-Gel encapsulation sphere’s diameter displayed by Au NP/gelatin (μmol/mg) ratio 
employed in the synthesis. 
 
NP/gelatin(10-
6μmol/mg)a,b 
 1.8 3.7 3.9 7.7 
En-Gel1 (NP1) dh(nm) 262.2c 296.1 ± 51.3 × × 
 PdI 0.231c 0.312 ± 0.034 × × 
En-Gel2 (NP3) dh (nm) × × 332.0 ± 25 104.6c 
 PdI × × 0.312 ± 0.037 0.178c 
 
aThese values refer to the amount (μmol) of NP1 or NP3 added for encapsulation with respect to starting 
amount (mg) of gelatin. b 5.00 μL/mg gelatin of a 0.9 % of EDC:NHS (3.5:1) .cExperiment carried out only 
once.  
 
Table 3.7: Au-Gel encapsulation sphere’s diameter displayed by Au NP/gelatin (μmol/mg) ratio 
employed in the synthesis. 
 
NP/gelatin (10-
6μmol/mg)a 
 1.4b b b c 
Au-Gel1 (NP2) dh 
(nm) 
289.8 ± 48.3    
 PdI 0.181 ± 0.06    
NP/gelatin (10-
6μmol/mg)a 
 2.3 4.6 6 12 
Au-Gel2 (NP4) dh 
(nm) 
355.0 ± 14.9 156.7d 267.1 ± 6.6 243.1d 
 PdI 0.195 ± 0.03 0.655b 0.206 ± 0.04 0.154d 
NP/gelatin (10-
6μmol/mg)a 
 1.9 3.7 6.1 12 
Au-Gel3 (NP5) dh 
(nm) 
297.3 ± 13.2 295.9d 289.1 ± 19.2 296.85 ± 14.5 
 PdI 0.267 ± 0.12 0.244d 0.251 ± 0.06 0.149 ± 0.07 
 
aThese values refer to the amount of NP2,NP4 or NP5 added for encapsulation with respect to starting 
amount (mg) of gelatin.b 5.00 μL/mg gelatin of a 0.9 % of EDC:NHS (3.5:1).c 2.67 μL/mg gelatin of a 0.9 % 
of EDC:NHS (3.5:1) .dExperiment carried out only once.  
 
Zetapotential 
Zetapotential is the tool applied for calculating surface charge and the 
results for free gold nanoparticles (NP1-5), gelatin nanoparticles, En-Gel and 
Au-Gel encapsulated material are display on Table 3.8. 
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Table 3.8:Zetapotentialresults obtained in mV.  
 
ZP (mV) NP1 NP2 NP3 NP4 NP5 Empty 
gelatin NPs 
Free AuNPa -11.7 -8.7b -15.0 ± 2.9 -17.2 ± 3.8 -16.0b × 
En-Gel 16.7b,c,g × 21.7b,d,g × × × 
Au-Gel × 18.6 ± 0.0e,g × 20.3b,f,h 22.9 ± 3.9f,h × 
Gelatin × × × × × 18.4b 
 
aNon encapsulated NP1-5 were measured at a concentration of 0.01mM. bA single measurement was 
performed. cThese nanoparticles were prepared using a ratio of 3.7 μmolNP per mg of gelatin. dThese 
nanoparticles were prepared using a ratio of 3.9 μmolNP per mg of gelatin. eThese nanoparticles were 
prepared using a ratio of 1.4 μmolNP per mg of gelatin.  fThese nanoparticles were prepared using a ratio 
of 6 μmolNP per mg of gelatin.g 5.00 μL/mg gelatin of a 0.9 % of EDC:NHS (3.5:1).h 2.67 μL/mg gelatin of 
a 0.9 % of EDC:NHS (3.5:1). 
  
As it is shown in Table 3.8 PEGylated gold nanoparticles surface is 
negatively charged. On the contrary, encapsulated nanoparticles following both 
pathways, that is, either by passive entrapment or by covalent bonding, show 
up positive values, thus, this is an indication that gold nanoparticles are mainly 
trapped inside gelatin and not linked or adsorbed on the surface of gelatin 
nanoparticles. 
 
 
 
 
 
 
Inductively coupled plasma – mass spectrometry (ICP-MS) 
With inductively coupled plasma coupled with mass spectrometry (ICP-
MS) quantitative elemental analysis of gold can be performed.  
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Table 3.9: Encapsulation Efficiency calculated based on initial NP1-5 concentration added in 
reaction vs. final quantity of Au in sample measured by ICP. 
 
 Au 
NPinitial(10-
3μmol) 
Au by 
ICP(𝝁𝒈/𝑳)a 
Au 
NPfinal(10-
4μmol) 
Au NP/gelatin 
(10-6μmol/mg)b 
EE 
(%) 
En-Gel1 
(NP1)c 
0.268 10.06 0.014 0.24 0.52 
En-Gel2 
(NP3)d 
0.579 29.57 0.061 0.71 1.05 
Au-Gel1 
(NP2) 
0.210e 
0.420f 
55.06 
254.23 
0.138 
1.060 
0.62 
2.46 
6.59 
25.35 
Au-Gel2 
(NP4) 
0.215f 
1.800g 
255.52 
944.21 
0.755 
3.980 
3.15 
22.10 
35.19 
22.16 
Au-Gel3 
(NP5) 
0.890h 
1.800g 
248.31 
437.24 
0.937 
1.690 
6.53 
5.09 
10.45 
9.40 
aData obtained for 6 mL of digested sample .bAmount of Au NP (µmol) per mg of Au-Gel NPs of the final 
product.cStarting from 3.7·10-6µmolNP per mg of gelatin.dStarting from 3.9·10-6µmolNP per mg of gelatin. 
eStarting from 0.7·10-6µmolNPper mg ofgelatin.f Starting from 1.4·10-6µmolNP per mg of gelatin. gStarting 
from 1.2·10-6µmolNP per mg of gelatin. hStarting from 6.0·10-6µmolNP per mg of gelatin. 
 
𝐸𝐸 = 100 −
(𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑜𝑙𝑠 𝑁𝑃 − 𝑓𝑖𝑛𝑎𝑙 𝑚𝑜𝑙𝑠 𝑁𝑃)
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑜𝑙𝑠 𝑁𝑃
· 100 
 
It has to be mentioned that encapsulation efficiency (EE) reflects only the 
amount of starting Au NPs that are incorporated in the final Au-Gel NPs, 
regardless of the amount or Au NPs pernanoparticle of gelatin. Indeed, through 
purification process, a second population of Au-Gel nanoparticles encapsulated 
is discarded due to their bigger size because the synthetic pathway applied on 
Au-Gel encapsulation does not offer a single homogeneous particle size. 
Hence, encapsulation efficiency percentages displayed in Table 3.9 are only 
those of nanoparticles under suitable diameter size range. However, what is 
more important for us is the amount of Au NPs inside each gelatin NP which 
was been reflected in Table 3.9 as the ratio of AuNPs (μmol) per mg of final 
gelatin NP, which is highest for Au-Gel2 with a value of 22.1·10-6 μmol/mg. 
Since we discarded En-Gel procedure due to low efficiency encapsulation 
we continued with further characterization of Au-Gel encapsulation as a very 
promising system. 
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Transmission electron microscopy (TEM) 
ZP in combination with TEM is a way to prove Au NPs are mostly 
encapsulated inside the gelatin nanospheres. TEM microscopy has been 
carried out in order to support these results and no free unattached gold NPs 
outside the gelatin ones have been detected at all in any TEM micrograph so 
far. This fact, together with no changes observed in ZP seems to confirm that 
gold NPs are actually encapsulated. 
In the following Figures we show selected TEM micrographs and size data 
for different Au-Gel NPs performed under negative staining. 
Au-Gel 1  
NP2/gelatin (10-
6μmol/mg)a 
1.4 
d (nm) by TEM 217.0 ± 62.8 
aAmount of NP2 added for encapsulation with 
respect to starting amount (mg) of gelatin. 
 
 
 
Au-Gel 2  
NP4/gelatin (10-
6μmol/mg)a 
4.60 
d (nm) by TEM 218.9 ± 52.1 
aAmount of NP4 added for encapsulation with 
respect to starting amount (mg) of gelatin. 
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Au-Gel 3  
NP5/gelatin (10-
6μmol/mg)a 
12.00 
d (nm) by TEM 206.9 ± 59.3 
aAmount of NP5 added for encapsulation with 
respect to starting amount (mg) of gelatin. 
 
 
 
Figure 3.10: TEM micrographs at different magnifications of Au-Gel1, Au-Gel2 and Au-Gel3. 
45 
 
 
Figure 3.11: Histograms with Gaussian distribution size of Au-Gel1, Au-Gel2 and Au-Gel3 (from 
left to right) calculated by Origin 8.5 software. 
 
As we can see on Figure 3.10 (plus statistics on Figure 3.11), there are no 
aggregates, particles are quite homogeneous, but still purificationcan be 
optimized. What TEM negative stain shows up is organic material, ergo, 
brightened contrast is gelatin. 
At this stage an important issue came up. Gelatin nanoparticles are 
soluble in water, also are gold nanoparticles. With first reaction conditions using  
1.4 - 4.6·10-6 µmol of Au NPs per mg of gelatin we did not encounter problems 
at all when resuspending final AuGel nanoparticles pellets after purification. 
Unfortunately increasing ratios to 6 and 12·10-6 µmol NP5 per mg gelatin we 
could not resuspend pellets easily in aqueous media, even applying heat and 
sonication. So we decided to revisit the crosslinking conditions used for these 
gelatin NPs preparation and we evaluated the use of less crosslinker to 
increase solubility of gelatin NPs.  
Indeed, less EDC/NHS quantity allows to resuspend Au-Gel nanoparticles 
successfully in water. We decided to reduce the amount of 0.9 % EDC/NHS 
(3.5:1) solution added to the reaction. Hence, we moved from initially optimized 
5 µL/mg of gelatin to 3.33 µL/mg and to 2.67 µL/mg (Table 3.10). In this 
manner, the rigidity of the gelatin NPs is reduced, hydration is favored, more 
free amino groups are available in gelatin after crosslinking and solubility is 
overall enhanced. 
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Table 3.10: Au-Gel encapsulation sphere’s diameter displayed by different crosslinker quantity. 
 
EDC/NHS 
solution per 
gelatin (μL/mg) 
 5.00 3.33 2.67 
Au-Gel 2 (2.30)a dh (nm) 354.4b 355.0 ± 14.9 288.5b 
 PdI 0.187b 0.199 ± 0.042 0.264b 
Au-Gel 3 (5.99)a dh (nm) 297.3 ± 13.2 × 257.9 ± 39.2 
 PdI 0.267 ± 0.12 × 0.271 ± 0.12 
 
aThe value in brackets refers to the amount of NP4 or NP5 added for encapsulation with respect to starting 
amount (mg) of gelatin .bA single measurement was performed 
 
Lastly, another issue was sorted out.In the initial experiments, after 1 hour 
reaction between gelatin and EDC/NHS activated NP5, red color was observed 
in the supernatant which meant that the covalent linkage between NP5 and 
gelatin chains was not achieved quantitatively (free nanoparticles remained in 
supernatant). We thought that several carboxyl groups either remained inactive 
due to accessibility problems and steric hindrance on the NP surface or were 
being hydrolized. Thus, the amount for EDC/NHS for the activation of gold 
nanoparticles was increased for NP5 from 56 to 100 equivalents of EDC, until 
the recovered supernatants were clear and without NPs in solution, meaning no 
NPs were recovered unattached after conjugation with gelatin. 
 
Nuclear Magnetic Resonance (NMR) 
Lastly, but mainly the top goal of the present work, we wanted to check if 
we could modulate the 19F NMR signal of the fluorinated gold NPs by 
encapsulation in gelatin, as the OFF state of our potential OFF/ON probe. 
Fluorine labeled gold nanoparticles display a single intense 19F NMR and 
19F MRI signal as already demonstrated.10 Besides, encapsulation of those 
particles was never tested before. For this reason, 19F NMR spectrum has been 
analyzed in order to check if gelatin encapsulation is able to quench fluorine 
signal from gold nanoparticles, as we hypothesized and as the first step towards 
our OFF/ON probe. 
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19F NMR spectra of non-encapsulated nanoparticles NP4 and Au-Gel 
nanoparticles where NP4 was encapsulated at equivalent gold NP 
concentration as calculated from ICP-MS analysis, were measured and the 
signal obtained was compared. 
 
 
 
Figure 3.12: 19F NMR of NP4 and Au-Gel2 encapsulated nanoparticles. Red spectrum 
corresponds to non-encapsulated NP4 at known concentration (0.25 μM), blue and green 
spectra correspond to Au-Gel2 at equivalent Au NP concentration at 37 and 25 ºC, respectively.  
 
As it can be observed in Figure 3.12 we successfully quenched 19F NMR 
signal through gelatin encapsulation both at room temperature (25 ºC) and at 
physiological temperature (37ºC). Last NMR spectrum shows 19F NMR of free 
nanoparticles at same concentration than encapsulated ones showing the 
characteristic peak for fluorine in these NPs, for comparison.   
Next, activation of the signal in the presence of MMP-9 is to be tested in 
the future, although this is beyond the time frame of this work.  
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4. Conclusion 
A new material has been designed with potential OFF/ON features with 
application in 19F magnetic resonance. Initially, passive trapping of gold 
nanoparticles was the goal but it was discarded due to low efficiency in 
encapsulation. The significant scientific advance is based on the covalent 
functionalization of gelatin chains with partially carboxylated and fluorinated 
gold nanoparticles.  
In the present work it has been proved that gold nanoparticles remain 
inside the gelatin sphere via two step desolvation method of encapsulation. 
NMR has demonstrated that gelatin encapsulation quenches fluorine signal 
successfully, thus, OFF state as the initial point of an activatable probe has 
been proved.  
Furthermore, it has to be mentioned that this process can be scaled up 
due to its simplicity. It is a non toxic procedure, ergo safe. This new material 
based on gelatin chain modification ensures high efficiency in encapsulation 
without losing gold nanoparticles making our system much more competent. 
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5. Materials and Methods 
5.1. Gelatin Nanoparticles synthesis  
General considerations:  
Gelatin type A and NHS were purchased from Sigma Aldrich and EDC 
from Fluka Analytical. Solvents (analysis quality) were purchased from Panreac 
and used as received. Water is MilliQ quality. A Sigma bench centrifuge was 
used for centrifugations. For reagent addition a WPI SP210IWZ syringe 
pumpwas used.  
Typical procedure:  
First step desolvation: The hot plate was set to 50 ºC and we waited until 
the temperature was stable. 300 mg of gelatin type A was weighted and placed 
in a 50 mL round bottom flask with a stirrer. 6 mL of nanopure-H2O was added, 
carefully without splashing the flask’s walls. The round bottom flask was put to 
heat stirring at 1000 rpm. After 10 min until complete dissolution was waited and 
then stirring was fixed to 750 rpm.  
6 mL acetone was added at once to the vortex of the solution smoothly 
with a syringe. Then we waited 4 seconds, removed the flask from the hot plate 
and high molecular weight gelatin precipitated during exactly 1 minute. The 
supernatant was poured out from the round bottom flask.  
Again 6 mL nano-H2O was added on the precipitate. The round bottom 
flask was put to heat with stirring at 1000 rpm and we leaved mixing for 10 min 
until complete dissolution. Then, the round bottom flask was took out and let it 
reach room temperature. pH of the solution was measured and adjusted 
carefully to 3.00 sharp by adding 1M HCl.  
Second step desolvation: The round bottom flask was taken back to the 
hot plate to 50 ºC and 750 rpm and we waited for 5 min in order to ensure it 
reached the desirable stirring rate and temperature. With a syringe pump was 
added 19.92 mL acetone at 1 mL/min rate to solution’s vortex (keeping 750 rpm 
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and 50 ºC conditions until reaction was over). After the addition of 
approximately 8 mL of acetone the reaction began to turn turbid.  
Subsequently, also with a syringe pump, freshly prepared 0.9 %EDC/NHS 
(3.5:1) solution was added according to the desirable crosslinkage amount 
(5.00 µL/mg of starting gelatin ratio. EDC/NHS solution was added at 0.1 
mL/min rate. The flask was covered and left reacting for 1h.  
Purification: After 1 hour, the crude reaction was transferred to two 10 mL 
centrifuge falcons. They were centrifuged at 2000 g once for 15 min at RT in 
SIGMA centrifuge. Resulting pellets (nanoparticles diameter between 500-350 
nm) were resuspend in 3 mL nano-pure water for further DLS characterization 
and stored. 
Supernatants were transferred in a new 10 mL falcon tube and centrifuged 
at 14000 g once for 20 min. The resulting pellets (nanoparticles diameter 
between 350-250 nm) were resuspended in 3 mL H2O nano-pure water for 
further DLS characterization and stored. Some pellets needed sonication and/or 
be heated to achieve successfully and homogeneous solution.  
Storage: Resulting samples were stored at 4 ºC to ensure long time 
colloidal stability. 
 
5.2. Gold nanoparticles synthesis  
General considerations:  
HAuCl4 was purchased from Strem Chemicals and NaBH4 from Sigma 
Aldrich. Solvents (analysis quality) were purchased from Panreac and used as 
received. Water is MilliQ quality. A Beckmann Coulter J-26XP floor 
ultracentrifuge was used for ultracentrifugations. Samples were introduced in 4 
mL Beckman centrifuge tubes. 
PEGylated ligands HS-PEG-OMe (2kDa) and HS-PEG-COOH (3kDa) 
were purchased from Rapp Polymere. Fluorinated PEG ligand HS-PEG-F (3 
kDa) was prepared in the laboratory as described by us (Scheme 3.3).10 
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General procedure: 
Synthesis: The corresponding PEGylated ligand (see Table 3.1) dissolved 
in CH2Cl2 (0.45 equiv.) were added under stirring onto CH2Cl2 (8 mL/µmol of 
HAuCl4).  
Subsequently, a solution of NaBH4 (0.1 M, 5 equiv.) was freshly prepared 
in ice-cold methanol, besides a solution of HAuCl4 (25 mM, 1 equiv.) in ice-cold 
methanol was added to the reaction mixture. One minute after the preparation 
of NaBH4 solution, the latter was added dropwise to the ligand/gold mixture 
already in the flask. When last NaBH4 drop was in solution reaction was stirred 
for 30 seconds. Afterwards, the resulting red solutiton was allowed to stand for 
at least 12 hours without stirring and capped to avoid solvent evaporation.  
Purification: After 12 hours, solvent was evaporated in the rotary 
evaporator and the so-obtained NPs were purified by ultracentrifugation. First, 2 
cycles of 2 hours at 150000 g were used to remove free unbound ligands and 
salts in the supernatant, and then 2 cycles of 30 minutes at 50000 g were used 
to discard aggregates and too big nanoparticles in the pellet. Hence NP1-5 
were recovered in the supernatant after 50000 g centrifugation as depicted in 
Figure 5.1.10 
 
 
Figure 5.1: Schematic representation of the workflow used to synthesize and purify gold 
nanoparticles. 
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5.3. Preparation of gelatin nanoparticles by passive encapsulation. 
Typical procedure:  
First step desolvation: The hot plate was set to 50ºC and waited until the 
temperature was stable. 300 mg of gelatin type A was weighted and placed in a 
50 mL round bottom flask with a stirrer. 6 mL nanopure-H2O was added, 
carefully without splashing the flask’s walls. The round bottom flask was put to 
heat stirring at 1000 rpm. We waited 10 min until complete dissolution and then 
fixed the stirring to 750 rpm.  
At once 6 mL acetone was added to the vortex of the solution smoothly 
with a syringe. Then after 4 seconds, the flask was removed from the hot plate 
and let high molecular weight gelatin precipitate for exactly 1 minute. The 
supernatant was poured out from the round bottom flask.  
Nanoparticles addition: Nanoparticles NP1 or NP3 prepared on section 
5.2. were added at known concentration onto the gelatin after first desolvation 
and water was added until the final volume was 6 mL. Solution was stirring for 
10 min at 50 ºC. Then, we took out the round bottom flask and leave it reach 
room temperature. pH of the solution was measured and adjusted carefully to 
3.00 sharp by adding 1M HCl.  
Second step desolvation: The round bottom flask was took back to the hot 
plate at 50ºC and 750 rpm and stirred for 30 min in order to ensure 
homogeneity. With a syringe pump 19.92 mL acetone was added at 1 mL/min 
rate to solution’s vortex (keeping 750 rpm and 50ºC conditions until reaction 
was over). After the addition of approximately 8 mL of acetone the reaction 
began to turn turbid.  
Subsequently, also with a syringe pump, freshly prepared 0.9 % EDC/NHS 
(3.5:1) solution was added according to the desirable crosslinkage amount 
(5.00 µL/mg of starting gelatin ratios). EDC/NHS solution was added at 0.1 
mL/min rate. The flask was covered and left reacting for 1h.  
 
53 
 
Purification: After 1 hour, the crude reaction was transfered to two 10 mL  
centrifuge falcons. They were centrifuged at 2000 g once for 15 min at RT in the 
SIGMA centrifuge. Resulting pellets (nanoparticles diameter between 500-350 
nm) were resuspened in 3 mL nano-pure water for further DLS characterization 
and stored. 
Supernatants were transferred in a new 10 mL falcon tube and centrifuged 
at 14000 g once for 20 min. The resulting pellets (nanoparticles diameter 
between 350-250 nm) were resuspended in 3 mL H2O nano-pure water for 
further DLS characterization and stored. Some pellets needed sonication and/or 
be heated to achieve successfully and homogeneous solution. 
Storage: Resulting samples were stored at 4 ºC to ensure long time 
colloidal stability. 
 
5.4. Preparation of Au-gelatin nanoparticles by covalent functionalization 
General procedure: 
Nanoparticles activation of carboxyl groups: Gold nanoparticles already 
prepared in section 5.2. NP2,4-5 at known concentration and selected amount 
(see Tables 3.7 and 3.9 for each condition tested) were transferred to avial for 
activation reaction. 
From previous ICP-MS data collected for similar gold nanoparticles in our 
group, it was estimated that there are approximately 140 ligands per 
nanoparticle, out of which 35 ligands are functionalized with COOH for NP2 and 
NP4, and 14 ligands for NP5. Therefore, at known concentration of NP2,4-5, we 
could estimate the concentration of COOH groups in solution (1 equiv.). 
For NP2 and NP4, the optimized NHS/EDC amounts were 85 equiv. NHS 
(5µM in water) followed by 249 equiv. EDC (5µM in water). For NP5 the 
optimized NHS/EDC amounts were 100 equiv. NHS (5 µM in water) followed by 
300 equiv. EDC (5 µM in water). 
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The reaction vial was heated at 40 ºC under orbital stirring at 300 rpm for 
30 min. Then, the activated AuNPs solution were filtered by centrifugation 
(Amicon filters 100 kDa MWCO) in order to remove non reacted EDC/NHS. 
Hence, the sample was centrifuged at 3500 g twice for 2 min at RT in the 
SIGMA centrifuge. Resulting purified nanoparticles were diluted to a fixed 
volume of 1.5 mL nano-pure water. 
First step desolvation: The hot plate was set to 50ºC and waited until the 
temperature was stable. 300 mg of gelatin type A were weighted and placed in 
a 50 mL round bottom flask with a stirrer. 6 mL nanopure-H2O was added, 
carefully without splashing the flask’s walls. The round bottom flask was put to 
heat stirring at 1000 rpm. We waited for 10 min until complete dissolution and 
then fixed the stirring to 750 rpm.  
At once 6 mL of acetone was added to the vortex of the solution smoothly 
with a syringe. Then after 4 seconds, the flask was removed from the hot plate 
and let high molecular weight gelatin precipitate for exactly 1 minute. The 
supernatant was poured out from the round bottom flask.  
Again 6 mL nano-H2O was addedon the precipitate. The round bottom 
flask was put to heat with stirring at 1000 rpm and mixed for 10 min until 
complete dissolution. 
This first desolvation step must be done before or in parallel to Au NPs 
activation to avoid Au NPs deactivation over time. 
Nanoparticles addition: with a syringe pump, the purified activated 
nanoparticles resuspended in 1.5 mL solution were added onto 6 mL gelatin 
solution at 0.1 mL/min speed (keeping 750 rpm and 50ºC reaction conditions). 
The mixture was allowed to react for 1 h. 
Au-Gel material purification: Onto resulting solution, we added at once 21 
mL of acetone into the round bottom flask in order to precipitate gelatin chains 
modified with Au NPs (still at 750 rpm and 50 ºC reaction conditions). 
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Then the solution was transferred to two 10 mL centrifuge falcon tubes 
and centrifuged once at 10000 g for 10 min at RT in the SIGMA centrifuge to 
remove unreacted gold nanoparticles.  
The so obtained pink gelatin pellet was transferred back into a round 
bottom flask. 6 mL nano-H2O was addedand heated at 50 ºC with 1000 rpm 
stirring for 10 min until complete dissolution of the gelatin pellet. 
Then, the round bottom flask was taken out from heat and stirring and 
leave it reach room temperature.pH of the solution was measured and adjusted 
carefully to 3.00 sharp by adding 1M HCl.  
Second step desolvation: The round bottom flask was taken to the hot 
plate to 50 ºC and 750 rpm and wait for 5 min in order to ensure it reaches the 
desirable stirring rate and temperature. With a syringe pump 19.92 mL acetone 
was added at 1 mL/min rate to solution’s vortex (keeping 750 rpm and 50ºC 
conditions until reaction was over). After the addition of approximately 8 mL of 
acetone the reaction began to turn turbid.  
Subsequently, also with a syringe pump, freshly prepared 0.9 % EDC/NHS 
(3.5:1) solution was added according to the desirable crosslinkage amount 
(Table 3.10 being 5.00 / 3.33 / 2.67 µL/mg of starting gelatin ratios). EDC/NHS 
solution was added at 0.1 mL/min rate. The flask was covered and left reacting 
for 1h. 
Purification: After 1 hour, the crude reaction was transferred to two 10 mL  
centrifuge falcons. They were centrifuged at 2000 g once 15 min at RT in the 
SIGMA centrifuge. Resulting pellets (nanoparticles diameter between 500-350 
nm) were resuspended in 3 mL nano-pure water for further DLS 
characterization and stored.  
Supernatants were transferred in a new 10 mL falcon tube and centrifuged 
at 14000 g once for 20 min. The resulting pellets (nanoparticles diameter 
between 350-250 nm) were resuspended in 3 mL H2O nano-pure water for 
further DLS characterization and stored. Some pellets needed sonication and/or 
be heated to achieve successfully and homogeneous solution.  
56 
 
Storage: Resulting samples were stored at 4 ºC to ensure long time 
colloidal stability. 
 
5.5. Characterisation techniques 
5.5.1. Dynamic light scattering (DLS) 
DLS experiments are based on the Brownian motion of the analyts within 
the dispersion medium is detected. More specifically, this is done by measuring 
the angular distribution of time/dependent scattered light intensity due to density 
and/or concentration fluctuations.30 This fluctuations give information of diffusion 
coefficient of the analyts sample. Thus, diffusion coefficient in turn represents 
the analyt’s Brownian motion. Finally, size is calculated based on measured 
velocity respect physic factors such viscosity and temperature. 
Hydrodinamic diameter (d(H)) can be calculated by Stokes-Einstein 
equation: 
 
Thereby, the measured diameter (d(H)) describes how the particles move 
within a liquid, thus, cannot be understand equivalent with the actual particle 
diameter. 
DLS displays average size, also polydispersity index (PI) giving 
information about the actual distortion of the monomodal light scattering signal. 
                                                          
30 Static and dynamic light scattering from branched polymers and biopolymers, Ed. Springer-Verlag. 
Berlin 1983. 
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The PI have values from 0-1 and, being 0 an ideal homogenous system and 1 
non homogenous distribution.  
DLS experiments were performed with Zetasizer (Nano ZS ZEN3600) 
detecting the scattered light at a fixed angle of 175º. Viscosity parameter was 
set up as pure water (i.e. 08872 cP at 25ºC). The experiments were performed 
at room temperature settled to 25 ºC in Zetasizer.  
 
5.5.2. Inductively coupled plasma-mass spectrometry (ICP-MS) 
Quantitative elemental analysis of gold can be performed by inductively 
coupled plasma coupled with mass spectrometry (ICP-MS). Dilution and acid 
digestion are required prior to analysis. For the case of our gold NP loaded 
gelatin NPs, 0.2 mL of gelatin NPs solution were firstly lyophilized and then 
digested with 1 mL of aqua regia (i.e. concentrated HCl (35 wt%) and HNO3 (67 
wt%) in 3:1 molar ratio) and then left overnight to allow oxidation of metallic 
cores into their corresponding ions. On next morning, 5 mL of HCl (2 %) were 
added before ICP-MS analysis. 
 
5.5.3. Transmission electron microscopy (TEM) 
All nanoparticles were analyzed by TEM to characterize the morphology of 
dry nanoparticles. The pictures were taken with a field transmission scanning 
electron microscope JEOL JEM-2100F working at 200 kV. 
Sampling preparation: by deposition of the sample (highly diluted) on top 
of a copper grid coated with a layer of carbon for standard TEM. For negative 
staining uranyl acetate was employed as the staining solution. In this manner, 
the background is stained, leaving the particle untouched, and thus visible. 
Size measurement was performed with free ImageJ software and size 
distribution analysis and histogram production was done with Origin® software. 
Selected TEM figures are displayed in Figures 3.4, 3.7 and 3.10 in section 
3. 
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5.5.4. Zetapotential (ζ) determination  
As the z potential cannot be measured directly, it is calculated from the 
electrophoretic mobility of an analyte, according to the Debey-Huckel-theory 
and the Helmholtz-Smoluchowski-equation. 
For the present study, we used a Zetasizer (Nano ZS ZEN3600). 
Measurements were performed in specific disposable cuvettes in water media 
(conductivity: 5.5·10-6 S/m). 
Zeta potentials values are displayed in Table 3.8 in section 3. 
 
5.5.5. Ultraviolet Visible Spectroscopy (UV-Vis) 
UV-Vis absorption spectra were measured in a spectrophotometer UV-Vis-
NIR Cary 5000 Varian. Normalized at λ = 450 nm. 
UV-Vis spectra are displayed in Figure 3.8 in section 3. 
In the case of fluorinated NP3-5, NP concentration for new batches was 
calculated by UV-Vis and ICP-MS calibration with the first batch of each NP. 
Hence, initially, increasing concentrations of gold NPs calculated by ICP were 
measured in UV-Vis and the absorbance at λ = 450 nm was plotted against 
concentration of NPs (μM). The so-obtained calibration graphs for NP3-5 are 
plotted in the Annex I. 
 
5.5.6. Nuclear Magnetic Resonance (NMR) 
19F NMR spectra were measured in a Bruker AVANCE (500MHz). 
Samples were carried out in water with a 20% of D2O.  
NMR spectra are displayed in Figures 3.9 and 3.12 in section 3. 
 
 
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
Annex I 
1. Calibration of NP3, NP4 and NP5. 
Calibration line was plotted concentration (µM) from ICP-MS data first 
batch of each NPs synthesized vs. absorbance.  
NP3: 100% HS-PEG- F 
 
Graph A: Calibration line of NP3. 
 
Figure A: UV-Vis absorption of NP3 at different concentrations. 
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NP4: 75% HS-PEG-F and 25% HS-PEG-COOH 
 
Graph B: Calibration line of NP4. 
 
Figure B: UV-Vis absorption of NP4 at different concentrations. 
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NP5: 75% HS-PEG-F and 25% HS-PEG-COOH 
 
Graph C: Calibration line of NP5. 
 
Figure C: UV-Vis absorption of NP5 at different concentrations. 
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2. Batch’s pictures 
 
 
Figure D: Empty gelatin nanoparticles batch after purification at 2k 
(discarded) and 14k (suitable) from left to right. 
 
 
 
Figure E: Gold nanoparticles after purification NP3 and NP5 from left to 
right. 
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Figure F: Au-Gel2 nanoparticles batch at 6 · 10-6 µmol NP4/mg gelatin 
after purification at 2k (discarded)  and 14k (suitable) from left to right. 
 
 
 
Figure G: Au-Gel2 nanoparticles batch at 12 ·10-6 µmolNP4/mg gelatin 
after purification at 14 k (suitable). 
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